On Monday, Iovance Biotherapeutics Inc (NASDAQ: IOVA) was -5.95% drop from the session before settling in for the closing price of $2.69. A 52-week range for IOVA has been $1.64 – $12.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 4.17% over the last five years. When this article was written, the company’s average yearly earnings per share was at 12.28%. With a float of $292.73 million, this company’s outstanding shares have now reached $341.92 million.
The firm has a total of 838 workers. Let’s measure their productivity.
Iovance Biotherapeutics Inc (IOVA) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Iovance Biotherapeutics Inc stocks. The insider ownership of Iovance Biotherapeutics Inc is 19.10%, while institutional ownership is 56.84%. The most recent insider transaction that took place on Jun 05 ’25, was worth 55,200. In this transaction Chief Commercial Officer of this company bought 30,000 shares at a rate of $1.84, taking the stock ownership to the 30,000 shares. Before that another transaction happened on May 23 ’25, when Company’s Chief Regulatory Officer bought 5,600 for $1.74, making the entire transaction worth $9,743. This insider now owns 206,852 shares in total.
Iovance Biotherapeutics Inc (IOVA) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.28 earnings per share (EPS) during the time that was better than consensus figure (set at -0.3) by 0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.61% during the next five years compared to 4.17% growth over the previous five years of trading.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Trading Performance Indicators
You can see what Iovance Biotherapeutics Inc (IOVA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 2.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.23, a number that is poised to hit -0.25 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Iovance Biotherapeutics Inc (IOVA)
Analysing the last 5-days average volume posted by the [Iovance Biotherapeutics Inc, IOVA], we can find that recorded value of 16.22 million was better than the volume posted last year of 13.83 million. As of the previous 9 days, the stock’s Stochastic %D was 64.66%.
During the past 100 days, Iovance Biotherapeutics Inc’s (IOVA) raw stochastic average was set at 33.12%, which indicates a significant decrease from 66.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.24 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.32, while its 200-day Moving Average is $4.49. Now, the first resistance to watch is $2.62. This is followed by the second major resistance level at $2.72. The third major resistance level sits at $2.77. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.42. Should the price break the second support level, the third support level stands at $2.32.
Iovance Biotherapeutics Inc (NASDAQ: IOVA) Key Stats
There are 361,854K outstanding shares of the company, which has a market capitalization of 915.48 million. As of now, sales total 164,070 K while income totals -372,180 K. Its latest quarter income was 59,950 K while its last quarter net income were -111,660 K.
